Raul Calero Oliver-rekin lankidetzan egindako argitalpenak (2)

2014

  1. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

    Oncogene, Vol. 33, Núm. 2, pp. 148-156

2009

  1. Novel tyrosine kinase inhibitors in the treatment of cancer

    Current Drug Targets, Vol. 10, Núm. 6, pp. 575-576